Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer

PURPOSE: Targeting the PD-1/PD-L1 pathway has emerged as a novel therapy for cancer. To identify rational candidates for anti-PD-1/PD-L1 immunotherapy in gastric cancer (GC), the abundance of PD-L1 expression was evaluated on a kind of biomarker-based molecular classification for shaping prognosis a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Manag Res
Hauptverfasser: Sun, Yeqi, Yu, Wenwei, Guan, Wenbin, Cai, Lei, Qiao, Meng, Zheng, Leizhen, Jiang, Ruiqi, Wang, Ruifen, Wang, Lifeng
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove 2019
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6630096/
https://ncbi.nlm.nih.gov/pubmed/31372044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S206189
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge